{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:18:08Z","timestamp":1793398688970,"version":"4.5.0"},"reference-count":31,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Cardiol"],"published-print":{"date-parts":[[2023,8,1]]},"abstract":"Importance<\/jats:title>Recent studies have produced inconsistent findings regarding the outcomes of the percutaneous microaxial left ventricular assist device (LVAD) during acute myocardial infarction with cardiogenic shock (AMICS).<\/jats:p><\/jats:sec>Objective<\/jats:title>To compare the percutaneous microaxial LVAD vs alternative treatments among patients presenting with AMICS using observational analyses of administrative data.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This comparative effectiveness research study used Medicare fee-for-service claims of patients admitted with AMICS undergoing percutaneous coronary intervention from October 1, 2015, through December 31, 2019. Treatment strategies were compared using (1) inverse probability of treatment weighting to estimate the effect of different baseline treatments in the overall population; (2) instrumental variable analysis to determine the effectiveness of the percutaneous microaxial LVAD among patients whose treatment was influenced by cross-sectional institutional practice patterns; (3) an instrumented difference-in-differences analysis to determine the effectiveness of treatment among patients whose treatment was influenced by longitudinal changes in institutional practice patterns; and (4) a grace period approach to determine the effectiveness of initiating the percutaneous microaxial LVAD within 2 days of percutaneous coronary intervention. Analysis took place between March 2021 and December 2022.<\/jats:p><\/jats:sec>Interventions<\/jats:title>Percutaneous microaxial LVAD vs alternative treatments (including medical therapy and intra-aortic balloon pump).<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>Thirty-day all-cause mortality and readmissions.<\/jats:p><\/jats:sec>Results<\/jats:title>Of 23\u202f478 patients, 14\u202f264 (60.8%) were male and the mean (SD) age was 73.9 (9.8) years. In the inverse probability of treatment weighting analysis and grace period approaches, treatment with percutaneous microaxial LVAD was associated with a higher risk-adjusted 30-day mortality (risk difference, 14.9%; 95% CI, 12.9%-17.0%). However, patients receiving the percutaneous microaxial LVAD had a higher frequency of factors associated with severe illness, suggesting possible confounding by measures of illness severity not available in the data. In the instrumental variable analysis, 30-day mortality was also higher with percutaneous microaxial LVAD, but patient and hospital characteristics differed across levels of the instrumental variable, suggesting possible confounding by unmeasured variables (risk difference, 13.5%; 95% CI, 3.9%-23.2%). In the instrumented difference-in-differences analysis, the association between the percutaneous microaxial LVAD and mortality was imprecise, and differences in trends in characteristics between hospitals with different percutaneous microaxial LVAD use suggested potential assumption violations.<\/jats:p><\/jats:sec>Conclusions<\/jats:title>In observational analyses comparing the percutaneous microaxial LVAD to alternative treatments among patients with AMICS, the percutaneous microaxial LVAD was associated with worse outcomes in some analyses, while in other analyses, the association was too imprecise to draw meaningful conclusions. However, the distribution of patient and institutional characteristics between treatment groups or groups defined by institutional differences in treatment use, including changes in use over time, combined with clinical knowledge of illness severity factors not captured in the data, suggested violations of key assumptions that are needed for valid causal inference with different observational analyses. Randomized clinical trials of mechanical support devices will allow valid comparisons across candidate treatment strategies and help resolve ongoing controversies.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamacardio.2023.1643","type":"journal-article","created":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T17:04:30Z","timestamp":1687367070000},"page":"744","source":"Crossref","is-referenced-by-count":44,"title":["Comparative Effectiveness of Percutaneous Microaxial Left Ventricular Assist Device vs Intra-Aortic Balloon Pump or No Mechanical Circulatory Support in Patients With Cardiogenic Shock"],"prefix":"10.1001","volume":"8","author":[{"given":"Zaid I.","family":"Almarzooq","sequence":"first","affiliation":[{"name":"Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology, Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, Massachusetts"},{"name":"Division of Cardiology, Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Song","sequence":"additional","affiliation":[{"name":"Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology, Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Issa J.","family":"Dahabreh","sequence":"additional","affiliation":[{"name":"Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology, Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, Massachusetts"},{"name":"CAUSALab, Harvard T.H. Chan School of Public Health, Boston, Massachusetts"},{"name":"Departments of Epidemiology and Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajar","family":"Kochar","sequence":"additional","affiliation":[{"name":"Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology, Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, Massachusetts"},{"name":"Division of Cardiology, Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico G.","family":"Ferro","sequence":"additional","affiliation":[{"name":"Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology, Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A.","family":"Secemsky","sequence":"additional","affiliation":[{"name":"Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology, Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline M.","family":"Major","sequence":"additional","affiliation":[{"name":"Office of Clinical Evidence and Analysis, Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Farb","sequence":"additional","affiliation":[{"name":"Office of Cardiovascular Devices, Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changfu","family":"Wu","sequence":"additional","affiliation":[{"name":"Office of Cardiovascular Devices, Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bram","family":"Zuckerman","sequence":"additional","affiliation":[{"name":"Office of Cardiovascular Devices, Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Yeh","sequence":"additional","affiliation":[{"name":"Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology, Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"key":"hoi230028r1","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ahj.2020.08.012","article-title":"Trends in first-time hospitalization, management, and short-term mortality in acute myocardial infarction-related cardiogenic shock from 2005 to 2017: a nationwide cohort study.","volume":"229","author":"Lauridsen","year":"2020","journal-title":"Am Heart J"},{"issue":"2","key":"hoi230028r2","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","article-title":"2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC).","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur Heart J"},{"issue":"4","key":"hoi230028r3","doi-asserted-by":"publisher","first-page":"e78","DOI":"10.1016\/j.jacc.2012.11.019","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines.","volume":"61","author":"O\u2019Gara","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"23","key":"hoi230028r4","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1016\/j.jacc.2015.10.017","article-title":"Hemodynamics of mechanical circulatory support.","volume":"66","author":"Burkhoff","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"hoi230028r5","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1161\/CIRCULATIONAHA.119.044007","article-title":"The evolving landscape of Impella use in the United States among patients undergoing percutaneous coronary intervention with mechanical circulatory support.","volume":"141","author":"Amin","year":"2020","journal-title":"Circulation"},{"issue":"8","key":"hoi230028r6","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1001\/jama.2020.0254","article-title":"Association of use of an intravascular microaxial left ventricular assist device vs intra-aortic balloon pump with in-hospital mortality and major bleeding among patients with acute myocardial infarction complicated by cardiogenic shock.","volume":"323","author":"Dhruva","year":"2020","journal-title":"JAMA"},{"issue":"18","key":"hoi230028r7","doi-asserted-by":"publisher","first-page":"e2152","DOI":"10.4244\/EIJ-D-17-00947","article-title":"National trends, predictors of use, and in-hospital outcomes in mechanical circulatory support for cardiogenic shock.","volume":"13","author":"Strom","year":"2018","journal-title":"EuroIntervention"},{"issue":"9","key":"hoi230028r8","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1001\/jamainternmed.2022.2735","article-title":"Clinical outcomes and cost associated with an intravascular microaxial left ventricular assist device vs intra-aortic balloon pump in patients presenting with acute myocardial infarction complicated by cardiogenic shock.","volume":"182","author":"Miller","year":"2022","journal-title":"JAMA Intern Med"},{"issue":"6","key":"hoi230028r9","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.amjcard.2016.11.037","article-title":"Effect of early initiation of mechanical circulatory support on survival in cardiogenic shock.","volume":"119","author":"Basir","year":"2017","journal-title":"Am J Cardiol"},{"issue":"6","key":"hoi230028r10","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.119.045169","article-title":"Letter by Chieffo et al regarding article, \"the evolving landscape of Impella use in the United States among patients undergoing percutaneous coronary intervention with mechanical circulatory support\".","volume":"142","author":"Chieffo","year":"2020","journal-title":"Circulation"},{"issue":"3","key":"hoi230028r11","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1001\/jama.2020.7551","article-title":"Intravascular microaxial left ventricular assist device vs intra-aortic balloon pump for cardiogenic shock.","volume":"324","author":"Rizzo","year":"2020","journal-title":"JAMA"},{"issue":"5","key":"hoi230028r13","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1097\/00001648-200009000-00011","article-title":"Marginal structural models and causal inference in epidemiology.","volume":"11","author":"Robins","year":"2000","journal-title":"Epidemiology"},{"issue":"1","key":"hoi230028r14","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/rssb.12300","article-title":"Robust causal inference with continuous instruments using the local instrumental variable curve.","volume":"81","author":"Kennedy","year":"2018","journal-title":"J R Stat Soc Series B Stat Methodol"},{"issue":"2","key":"hoi230028r15","first-page":"517","article-title":"The derivation of a latent threshold instrumental variables model.","volume":"10","author":"Glickman","year":"2000","journal-title":"Stat Sin"},{"key":"hoi230028r18","doi-asserted-by":"publisher","DOI":"10.1111\/0034-6527.00321","author":"Abadie","year":"2005","journal-title":"Review of Economic Studies"},{"key":"hoi230028r19","doi-asserted-by":"publisher","DOI":"10.1111\/biom.v79.2","article-title":"Instrumented difference-in-differences.","author":"Ye","journal-title":"Biometrics"},{"issue":"6","key":"hoi230028r20","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.1097\/EDE.0000000000000884","article-title":"Re: multivessel percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction with cardiogenic shock.","volume":"29","author":"Secemsky","year":"2018","journal-title":"Epidemiology"},{"issue":"1","key":"hoi230028r21","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0304-4076(96)01805-2","article-title":"The marginal cost-effectiveness of medical technology: a panel instrumental-variables approach.","volume":"77","author":"McClellan","year":"1997","journal-title":"J Econom"},{"issue":"434","key":"hoi230028r22","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1080\/01621459.1996.10476902","article-title":"Identification of causal effects using instrumental variables.","volume":"91","author":"Angrist","year":"1996","journal-title":"J Am Stat Assoc"},{"issue":"8","key":"hoi230028r23","doi-asserted-by":"publisher","first-page":"e254","DOI":"10.1161\/CIR.0000000000000950","article-title":"Heart disease and stroke statistics-2021 update: a report from the American Heart Association.","volume":"143","author":"Virani","year":"2021","journal-title":"Circulation"},{"issue":"1","key":"hoi230028r24","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/ccd.28329","article-title":"SCAI clinical expert consensus statement on the classification of cardiogenic shock.","volume":"94","author":"Baran","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"issue":"7","key":"hoi230028r25","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1002\/ccd.28307","article-title":"Improved outcomes associated with the use of shock protocols: updates from the National Cardiogenic Shock Initiative.","volume":"93","author":"Basir","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"issue":"19","key":"hoi230028r26","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1016\/j.jacc.2015.03.036","article-title":"2015 SCAI\/ACC\/HFSA\/STS clinical expert consensus statement on the use of percutaneous mechanical circulatory support devices in cardiovascular care: endorsed by the American Heart Association, the Cardiological Society of India, and Sociedad Latino Americana de Cardiologia Intervencion; Affirmation of Value by the Canadian Association of Interventional Cardiology-Association Canadienne de Cardiologie d\u2019intervention.","volume":"65","author":"Rihal","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"hoi230028r27","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.37748","article-title":"Use of mechanical circulatory support devices among patients with acute myocardial infarction complicated by cardiogenic shock.","volume":"4","author":"Dhruva","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"17","key":"hoi230028r28","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1056\/NEJMp1310102","article-title":"The randomized registry trial\u2013the next disruptive technology in clinical research?","volume":"369","author":"Lauer","year":"2013","journal-title":"N Engl J Med"},{"issue":"8","key":"hoi230028r29","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1093\/aje\/kwaa270","article-title":"Study designs for extending causal inferences from a randomized trial to a target population.","volume":"190","author":"Dahabreh","year":"2021","journal-title":"Am J Epidemiol"},{"issue":"8","key":"hoi230028r30","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1093\/aje\/kwv254","article-title":"Using big data to emulate a target trial when a randomized trial is not available.","volume":"183","author":"Hern\u00e1n","year":"2016","journal-title":"Am J Epidemiol"},{"key":"hoi230028r12","volume-title":"Causal Inference: What If","year":"2020"},{"key":"hoi230028r16","volume-title":"Mostly Harmless Econometrics: An Empiricist's Companion","year":"2009"},{"key":"hoi230028r17","doi-asserted-by":"crossref","unstructured":"Blandhol? C, Bonney? J, Mogstad? M, Torgovitsky? A. When is TSLS actually LATE? National Bureau of Economic Research Working Paper Series. Revised August 2022. Accessed May 16, 2023. doi:10.3386\/w29709","DOI":"10.3386\/w29709"},{"key":"hoi230028r31","unstructured":"Dang LE, Gruber S, Lee H, et al. A causal roadmap for generating high-quality real-world evidence. arXiv. Preprint posted May 11, 2023. doi:10.48550\/arXiv.2305.06850"}],"container-title":["JAMA Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/articlepdf\/2806562\/jamacardiology_almarzooq_2023_oi_230028_1690482631.71459.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T15:03:02Z","timestamp":1691593382000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/fullarticle\/2806562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,1]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamacardio.2023.1643","relation":{},"ISSN":["2380-6583"],"issn-type":[{"value":"2380-6583","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,1]]}}}